🏛️ Verified NIH Record • Updated 2025-07-02
A Study to Compare the Efficacy and Safety of SCENESSE and Narrow-Band Ultraviolet (NB-UVB) Light Versus NB-UVB Light Alone in Patients With Vitiligo (NCT06109649)
A Double-Arm, Open Label, Phase III Study to Compare the Efficacy and Safety of SCENESSE and Narrow-Band Ultraviolet B (NB-UVB) Light Versus NB-UVB Light Alone in the Treatment of Vitiligo
🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic Sponsor: Clinuvel, Inc.
🩺 Plain-English Summary (8th-Grade Level)
The CUV105 study will assess the efficacy and safety of afamelanotide and NB-UVB light in patients with vitiligo on the body and face versus NB-UVB light alone.
Who can join: Review the eligibility criteria below.
Location: CLINUVEL site — Birmingham, Alabama
Age range: 12 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (30 Sites)
Showing the first 25 of 30 sites.
- CLINUVEL site — Birmingham, Alabama
- CLINUVEL site — Fresno, California
- CLINUVEL site — Los Angeles, California
- CLINUVEL site — Palo Alto, California
- CLINUVEL site — San Diego, California
- CLINUVEL Site — Washington D.C., District of Columbia
- CLINUVEL site — Miami, Florida
- CLINUVEL site — Miramar, Florida
- CLINUVEL site — Alpharetta, Georgia
- CLINUVEL site — Augusta, Georgia
- CLINUVEL site — Chicago, Illinois
- CLINUVEL site — Baton Rouge, Louisiana
- CLINUVEL site — Detroit, Michigan
- CLINUVEL site — Minneapolis, Minnesota
- CLINUVEL site — Roseville, Minnesota
- CLINUVEL Site — Lee's Summit, Missouri
- CLINUVEL site — Rochester, New York
- CLINUVEL site — Cleveland, Ohio
- CLINUVEL site — Philadelphia, Pennsylvania
- CLINUVEL Site — Charleston, South Carolina
- CLINUVEL site — Thompson's Station, Tennessee
- CLINUVEL Site — Cedar Park, Texas
- CLINUVEL site — Dallas, Texas
- CLINUVEL site — Tyler, Texas
- CLINUVEL site — Charlottesville, Virginia
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Vitiligo
- Daily Topical Rapamycin for Vitiligo — Charleston, South Carolina
- A Study To Assess Adverse Events and Effectiveness of Upadacitinib Oral Tablets in Adult and Adolescent Participants With Vitiligo — Glendale, Arizona
- A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo — Encinitas, California
- A Trial to Test the Safety and Efficacy of TEV-53408 in Treating Vitiligo — Scottsdale, Arizona
- An Observational Study of Patients With Dermatologic Disease — Winston-Salem, North Carolina
Explore by condition: All Vitiligo clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.